Your browser doesn't support javascript.
loading
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial.
Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling; Li, Wei; Jiang, Qian; Wang, Xiuli; Huang, Jinwen; Zhu, Huanling; Yang, Linhua; Du, Xin; Li, Fei; Xia, Ruixiang; Zhang, Feng; Hu, Jianda; Li, Yan; Hu, Yu; Liu, Jing; Jin, Chenghao; Sun, Kai; Zhou, Zeping; Wu, Liqing; Yu, Wenjuan; Jin, Jie.
Afiliação
  • Zhang Y; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China.
  • Zhou H; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, P.R. China.
  • Jiang Z; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, P.R. China.
  • Wu D; Zhejiang University Cancer Center, Hangzhou, P.R. China.
  • Zhuang J; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, P.R. China.
  • Li W; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
  • Jiang Q; Department of Hematology, Xiangya Hospital, Central South University, Changsha, P.R. China.
  • Wang X; Department of Hematology, Peking Union Medical College Hospital (Dongdan Campus), Beijing, P.R. China.
  • Huang J; Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, P.R. China.
  • Zhu H; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell, Beijing, P.R. China.
  • Yang L; Department of Oncology Hematology, The Second Hospital of Jilin University, Changchun, P.R. China.
  • Du X; Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China.
  • Li F; Department of Hematology, West China Hospital, Sichuan University, Chengdu, P.R. China.
  • Xia R; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, P.R. China.
  • Zhang F; Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, P.R. China.
  • Hu J; Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, P.R. China.
  • Li Y; Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China.
  • Hu Y; Department of Hematology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, P.R. China.
  • Liu J; Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, P.R. China.
  • Jin C; Department of Hematopathology, The First Hospital of China Medical University, Shenyang, P.R. China.
  • Sun K; Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
  • Zhou Z; Department of Hematology, Third Xiangya Hospital of Central South University, Changsha, P.R. China.
  • Wu L; Department of Hematology, Jiangxi Provincial People's Hospital, Nanchang, P.R. China.
  • Yu W; Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, P.R. China.
  • Jin J; Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, P.R. China.
Am J Hematol ; 97(12): 1510-1519, 2022 12.
Article em En | MEDLINE | ID: mdl-36054786
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases / Anemia Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases / Anemia Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2022 Tipo de documento: Article